151 related articles for article (PubMed ID: 17803583)
1. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
[TBL] [Abstract][Full Text] [Related]
2. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
[TBL] [Abstract][Full Text] [Related]
4. Confirmed graft flow following use of recombinant factor VIIa in coronary artery bypass grafting: a case report and literature review.
Beldowicz BC; McDonald JM; Needham CS
J Card Surg; 2006; 21(5):483-6. PubMed ID: 16948764
[TBL] [Abstract][Full Text] [Related]
5. [Our experience with recombinant activated factor VII (NovoSeven) in the high risk cardiosurgical patients with bleeding complication].
Miskolczi S; Vaszily M; Papp C; Péterffy A
Magy Seb; 2008; 61 Suppl():45-7. PubMed ID: 18504237
[TBL] [Abstract][Full Text] [Related]
6. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
7. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant activated factor VII after axillofemoral bypass grafting.
Cheng CA; Ho AM
Anaesth Intensive Care; 2006 Jun; 34(3):375-8. PubMed ID: 16802495
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
10. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
Kogan A; Berman M; Stein M; Vidne BA; Raanani E
J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
[TBL] [Abstract][Full Text] [Related]
11. Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery.
Halkos ME; Levy JH; Chen E; Reddy VS; Lattouf OM; Guyton RA; Song HK
Ann Thorac Surg; 2005 Apr; 79(4):1303-6. PubMed ID: 15797067
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.
DiDomenico RJ; Massad MG; Kpodonu J; Navarro RA; Geha AS
Chest; 2005 May; 127(5):1828-35. PubMed ID: 15888865
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Tobias JD; Simsic JM; Weinstein S; Schechter W; Kartha V; Michler R
J Intensive Care Med; 2004; 19(5):270-3. PubMed ID: 15358945
[TBL] [Abstract][Full Text] [Related]
14. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
McCall P; Story DA; Karalapillai D
Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
[TBL] [Abstract][Full Text] [Related]
15. Thrombogenic side-effects of recombinant factor VIIa after use in coronary artery bypass surgery.
White MC; Pryn SJ; Monk CR
Anaesth Intensive Care; 2006 Oct; 34(5):664-7. PubMed ID: 17061646
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII in paediatric cardiac surgery.
Egan JR; Lammi A; Schell DN; Gillis J; Nunn GR
Intensive Care Med; 2004 Apr; 30(4):682-5. PubMed ID: 14685661
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
18. Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery.
Mahmoud A; Al-Ruzzeh S; McKeague H; Cross M
Tex Heart Inst J; 2007; 34(4):485-8. PubMed ID: 18172537
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery.
von Heymann C; Hotz H; Konertz W; Kox WJ; Spies C
J Cardiothorac Vasc Anesth; 2002 Oct; 16(5):615-6. PubMed ID: 12407617
[No Abstract] [Full Text] [Related]
20. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
Yan Q; Chang AC
Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
